Exercise therapy for fatigue in multiple sclerosis

M Heine, I van de Port, MB Rietberg… - Cochrane database …, 2015 - cochranelibrary.com
Background Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous
system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of …

Distinguishing between fatigue and fatigability in multiple sclerosis

RM Enoka, AM Almuklass, M Alenazy… - … and Neural Repair, 2021 - journals.sagepub.com
Fatigue is one of the most common debilitating symptoms reported by persons with multiple
sclerosis (MS). It reflects feelings of tiredness, lack of energy, low motivation, and difficulty in …

[HTML][HTML] The pathophysiology of motor fatigue and fatigability in multiple sclerosis

R Patejdl, UK Zettl - Frontiers in Neurology, 2022 - frontiersin.org
Multiple Sclerosis (MS) is a heterogeneous immune mediated disease of the central nervous
system (CNS). Fatigue is one of the most common and disabling symptom of MS. It interferes …

Sarcopenia in patients with multiple sclerosis

H Yuksel, M Balaban, OO Tan, S Mungan - Multiple Sclerosis and Related …, 2022 - Elsevier
Background: Multiple sclerosis (MS) is an autoimmune neurodegenerative disease of the
central nervous system. Sarcopenia, which is characterized by the loss of physical …

Validity and reliability of the fatigue severity scale in a real-world interstitial lung disease cohort

KI Aronson, AM Martin-Schwarze… - American Journal of …, 2023 - atsjournals.org
Rationale: Fatigue is a common and debilitating symptom for people living with interstitial
lung disease (ILD). Studies on fatigue in ILD are limited, and little headway has been made …

Fatigue in hypokinetic, hyperkinetic, and functional movement disorders

IA Di Vico, G Cirillo, A Tessitore, M Siciliano… - Parkinsonism & related …, 2021 - Elsevier
The emerging science of fatigue has soundly endorsed the need for its unified definition,
shared terminology and increased recognition in neurological illnesses. Nevertheless, the …

[HTML][HTML] Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis

S Kontaxis, E Laporta, E Garcia, AI Guerrero… - Frontiers in …, 2023 - frontiersin.org
Objective: The aim of this study was to evaluate the association between changes in the
autonomic control of cardiorespiratory system induced by walk tests and outcome measures …

Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial

L Voggenberger, M Böck, D Moser… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background Fatigue is a common symptom in people with multiple sclerosis (pwMS) that
significantly impairs quality of life. Bright light therapy may be a cheap treatment option with …

[HTML][HTML] Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1. 0–Fatigue (MS) 8a

P Kamudoni, J Johns, KF Cook, R Salem… - Multiple Sclerosis and …, 2021 - Elsevier
Background Fatigue is one of the most common and the single most disabling symptom of
multiple sclerosis (MS). However, there is a lack of consensus on the most appropriate …

[HTML][HTML] Instrumented assessment of motor performance fatigability during the 6-min walk test in mildly affected people with multiple sclerosis

KC Broscheid, M Behrens, P Bilgin-Egner… - Frontiers in …, 2022 - frontiersin.org
There are conflicting results regarding the changes in spatio-temporal gait parameters
during the 6-min walk test (6MWT) as indicators of gait-related motor performance fatigability …